About CISSS de la Monteregie-Centre
Clinical Trials at CISSS de la Monteregie-Centre
During the past decade, CISSS de la Monteregie-Centre conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 7 clinical trials were completed, i.e. on
average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CISSS de la Monteregie-Centre" #1 sponsor was "Allergan" with 2 trials, followed by "Purdue Pharma, Canada" with 2 trials
sponsored, "Incyte Corporation" with 1 trials sponsored, "Janssen Scientific Affairs, LLC" with 1 trials sponsored and "Montreal Heart Institute"
with 1 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CISSS de la Monteregie-Centre"
#1 collaborator was "AbbVie" with 1 trials as a collaborator, "Apotex Inc." with 1 trials as a collaborator, "Arch Biopartners Inc." with 1 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at CISSS de la Monteregie-Centre
According to Clinical.Site data, the most researched conditions in "CISSS de la Monteregie-Centre" are
"Gastroparesis" (2 trials), "Atrial Fibrillation and Flutter" (1 trials), "Breast Cancer" (1 trials), "COVID-19" (1 trials) and "Chemotherapy-Induced Nausea and Vomiting" (1 trials). Many other conditions were trialed in "CISSS de la Monteregie-Centre" in a lesser frequency.
Clinical Trials Intervention Types at CISSS de la Monteregie-Centre
Most popular intervention types in "CISSS de la Monteregie-Centre" are "Drug" (13 trials), "Biological" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "300mg netupitant/0.5mg palonosetron hydrochloride" (1 trials), "Adalimumab (40 mg)" (1 trials), "Artesunate" (1 trials) and "Brentuximab vedotin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CISSS de la Monteregie-Centre
The vast majority of trials in "CISSS de la Monteregie-Centre" are
14 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at CISSS de la Monteregie-Centre
Currently, there are NaN active trials in "CISSS de la Monteregie-Centre".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in CISSS de la Monteregie-Centre,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in CISSS de la Monteregie-Centre, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".